Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. (Q37403226)
Jump to navigation
Jump to search
scientific article published on 21 September 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. |
scientific article published on 21 September 2009 |
Statements
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib (English)
Francis Giles
1 reference
Ronan Swords
Devalingam Mahalingam
Swaminathan Padmanabhan
Jennifer Carew
21 September 2009
1 reference
1 reference